DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION

Cognex Corporation

NasdaqGS:CGNX Stock Report

Market Cap: US$10.4b

  • Company Overview
    • Valuation
    • Future Growth
    • Past Performance
    • Financial Health
    • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Cognex Management

Management criteria checks 2/4

Cognex's CEO is Matt Moschner, appointed in Feb 2025, has a tenure of 1.58 years. total yearly compensation is $8.10M, comprised of 6.5% salary and 93.5% bonuses, including company stock and options. directly owns 0.006% of the company’s shares, worth $670.02K. The average tenure of the management team and the board of directors is 1.6 years and 4.3 years respectively.

Key information

Matt Moschner

Chief executive officer

US$8.1m

Total compensation

CEO salary percentage6.53%
CEO tenure1.6yrs
CEO ownership0.006%
Management average tenure1.6yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

User avatar
Narrative Update • Aug 21

CGNX: AI Vision Demand And Mixed Margin Outlook Will Shape Fair Prospects

Cognex's updated analyst price target framework reflects a modest fair value shift to about $65.87, with analysts pointing to a more supportive organic growth outlook, operating expense leverage and AI driven demand themes, balanced against pressure on profit margins and a higher assumed future P/E of about 43x. Analyst Commentary Recent research on Cognex shows a mixed backdrop.
Seeking Alpha • Aug 12

Cognex: The Data Center Supply Chain Play The Market Is Underpricing; Strong Buy

Summary Cognex Corporation is poised for durable, margin-accretive growth, driven by expansion into the data center and semiconductor markets. CGNX’s OneVision platform and AI-enabled inspection solutions position it to capture significant upside from the global data center buildout and server refresh cycles. Despite near-term margin headwinds from rising memory costs, I expect robust operating leverage and margin expansion, with an inflection point in eFY27. I reiterate a Strong Buy rating on CGNX with a $95/share price target, viewing current valuation as a modest long-term buying opportunity. Read the full article on Seeking Alpha
User avatar
Narrative Update • Aug 07

CGNX: AI Vision Systems And Margin Expansion Will Support Premium Multiple

Cognex now carries an updated analyst price target framework of $80.42, with recent Street research pointing to higher targets in the $72 to $91 range as analysts factor in AI driven vision systems, end market diversification, and improved margin assumptions. Analyst Commentary Recent Street research on Cognex clusters around a constructive view on AI enabled vision systems, a broader customer base, and scope for better profitability.
User avatar
Narrative Update • Jul 02

CGNX: AI Vision Expansion And End Market Diversification Will Support Fair Outlook

Cognex's updated analyst price framework reflects a modest fair value lift to $64.14 from $61.65, with analysts tying higher targets, often in the $60s to mid $70s range, to AI enabled product progress, broader end market exposure, and more constructive views on revenue growth, margins, and future P/E assumptions. Analyst Commentary Recent Street research on Cognex highlights a mixed but generally constructive tone, with several firms lifting price targets and, in one case, upgrading the stock on the back of AI enabled vision systems, broader end market exposure, and sales model changes.
Analysis Article • Jun 20

Cognex (CGNX) Stock Could Be 13.3% Undervalued After Zacks Rank Upgrade

Cognex (CGNX) has moved into focus after being added to the Zacks Rank #1 (Strong Buy) list, a shift driven by a higher consensus earnings estimate for its machine vision business. See our latest analysis for Cognex. Cognex’s recent earnings estimate upgrade and macro driven swings have come against a backdrop of strong share price momentum, with a 90 day share price return of 34.24% and a 1 year total shareholder return of 124.77%. This suggests recent optimism is building on an already...
User avatar
Narrative Update • Jun 18

CGNX: AI Vision Expansion And Margin Execution Will Support Premium Stock Multiple

Analysts have raised the implied fair value for Cognex to $76.25 from $65.60, citing higher assumed revenue growth, stronger profit margins, and a series of recent price target increases related to AI-enabled vision systems and an expanding customer base. Analyst Commentary Recent research on Cognex points to a clear split between enthusiasm for the company’s AI-enabled vision systems and a more measured view on how quickly those strengths translate into sustained growth and returns.
User avatar
Narrative Update • Jun 03

CGNX: AI Vision Turnaround And Cost Discipline Will Support Fairly Valued Outlook

Narrative Update: Cognex Analyst Price Target Move The analyst price target for Cognex is updated from $50.92 to $61.65, with analysts citing AI-enabled vision systems, a broader customer base, an improved mix, and expense leverage as key factors supporting higher fair value assumptions. Analyst Commentary Recent research updates around Cognex point to a more constructive tone on growth opportunities tied to AI enabled vision systems and a broader customer base, but there is still a pocket of caution that centers on how much of this optimism is already reflected in the stock price and how consistently the company can execute.
User avatar
Narrative Update • May 19

CGNX: Margin Execution And Automation Demand Will Drive Future Share Upside

Analysts have lifted the updated price target framework for Cognex to $90.99 from $60.96, citing broad Street target increases. These changes reflect a more favorable organic growth outlook, stronger gross margin performance, and ongoing operating expense leverage.
Analysis Article • May 09

Cognex Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Cognex Corporation ( NASDAQ:CGNX ) just released its quarterly report and things are looking bullish. The company beat...
User avatar
Narrative Update • Apr 28

CGNX: Margin Discipline And End Market Recovery Will Support Fairly Valued Outlook

Cognex's analyst price target has slipped slightly from about $52 to $50.92 as analysts balance a softer revenue growth outlook with firmer margin expectations and still elevated P/E assumptions. Analyst Commentary Recent research on Cognex shows a split view, with some firms lifting targets and ratings while others are taking a more restrained stance as they reassess growth, margins, and valuation after the latest earnings updates.
User avatar
Narrative Update • Apr 14

CGNX: Margin Execution And Buybacks Will Support Premium Multiple In Recovery

The analyst price target for Cognex has edged up by $0.10 to $65.60 as analysts highlight margin improvement efforts, cost reduction plans, and a recovering demand backdrop across key end markets. Analyst Commentary Recent research signals a generally constructive shift in sentiment on Cognex, with several banks lifting price targets and a few moving ratings higher as they reassess earnings power, margins, and the demand backdrop.
User avatar
Narrative Update • Mar 31

CGNX: Margin Discipline And Buybacks Will Support Premium Multiple In Industrial Recovery

Analyst price targets on Cognex have moved higher, with the updated fair value estimate holding at $65.50. Analysts point to margin improvement, cost initiatives, a recovering short cycle industrial group, and steadier segment trends as key supports for the new targets.
User avatar
Narrative Update • Mar 17

CGNX: Margin Execution And Buybacks Will Support Premium Multiple In Industrial Recovery

Cognex's analyst fair value estimate has been revised higher from $60.55 to $65.50. Analysts highlight improving short cycle industrial demand, faster margin progress, cost reduction efforts, and a broader customer base, which support higher revenue growth assumptions and a richer future P/E of 44.37x versus 41.32x previously.
User avatar
Narrative Update • Mar 02

CGNX: Margin Execution And Demand Stability Will Shape Fairly Valued Outlook

The analyst fair value estimate for Cognex has been raised from $36.62 to $52.00, reflecting higher Street price targets in the $55 to $75 range and analyst expectations for improved margins, cost control, and a more stable demand backdrop across key segments. Analyst Commentary Recent Street research on Cognex clusters around higher price targets and a more constructive stance on margins, cost controls, and demand stability, but the tone is not uniformly bullish.
Analysis Article • Feb 19

We Like The Quality Of Cognex's (NASDAQ:CGNX) Earnings

Investors signalled that they were pleased with Cognex Corporation's ( NASDAQ:CGNX ) most recent earnings report. This...
User avatar
Narrative Update • Feb 16

CGNX: Cost Discipline And Automation Demand Will Support Margins And Buybacks

Analysts have raised their price target on Cognex by about $11.90 to $60.55, citing updated assumptions around fair value, discount rate, revenue growth, profit margins, and future P/E multiples, which are in line with recent Street target increases from UBS, Barclays, and KeyBanc. Analyst Commentary Recent target changes around Cognex reflect a mix of optimism on long term demand drivers and some caution on execution and timing, with several firms adjusting their models as part of broader industrial technology outlooks for 2026.
User avatar
Narrative Update • Feb 02

CGNX: Industrial Tech Tailwinds Will Face Stricter Execution And Margin Expectations

Analysts have trimmed their price target on Cognex to US$54, down US$2, as they refresh assumptions around fair value, discount rate, revenue growth, profit margin, and future P/E in light of updated views on industrial technology demand across data centers, factory and warehouse automation, electronics, test and measurement, and semiconductors. Analyst Commentary Recent research trims the price target on Cognex to US$54, which signals that some expectations around future growth, margins, and valuation are being reset, even as broader industrial technology end markets such as data centers, factory automation, warehouse automation, electronics, test and measurement, and semiconductors are viewed constructively.
User avatar
Narrative Update • Jan 19

CGNX: Cost Cuts And Automation Exposure Will Drive Future Share Upside

Analysts have trimmed their average price target for Cognex by about $2 to roughly $54, reflecting updated views on fair value, discount rate, growth, margins and future P/E after recent sector wide adjustments to industrial technology outlooks. Analyst Commentary Recent Street commentary around Cognex centers on small adjustments to fair value assumptions while keeping a generally constructive view on the company and its exposure to industrial technology end markets.
User avatar
Narrative Update • Jan 05

CGNX: Cost Discipline And Activist Pressure Will Drive Stronger Margins

Analysts have nudged their price target for Cognex slightly higher, reflecting a modest fair value increase to about $48.65 as they anticipate margin recovery and stronger 2025 EBITDA, supported by continued R&D investment and disciplined cost control. Analyst Commentary Bullish Takeaways Bullish analysts highlight expectations for a strong EBITDA recovery in 2025, supported by top line growth and disciplined expense management, which underpins the higher fair value range.
User avatar
Narrative Update • Dec 21

CGNX: EBITDA Recovery And Cost Cuts Will Drive Strong Share Upside

Analysts have raised their price target on Cognex to a range centered around approximately $55, up from the prior mid $30s to low $40s range. They cite expectations for stronger revenue growth, higher profit margins, and a robust EBITDA recovery supported by disciplined expense management and sustained R&D investment.
User avatar
Narrative Update • Dec 07

CGNX: Cost Discipline And Activist Pressure Will Drive Stronger Margins And Earnings

Analysts have nudged their average price target on Cognex slightly higher, with recent moves such as a lift to about $45 and a bullish $55 initiation. These changes reflect expectations for a measured recovery in growth and margins, supported by stronger 2025 EBITDA and disciplined cost control.
User avatar
Narrative Update • Nov 23

CGNX: Cost Reductions And Expense Discipline Will Drive Earnings Recovery In 2025

The analyst price target for Cognex has increased from $37 to $45. Analysts cite improved profit margins and expectations for stronger EBITDA recovery, driven by disciplined expense management and robust investments in R&D and sales.
User avatar
Narrative Update • Nov 06

CGNX: Expense Discipline And Cost Cuts Will Drive Stronger Margins Ahead

The analyst price target for Cognex has increased from $48.25 to $48.90, as analysts note improving margin prospects beyond near-term tariff headwinds. They also anticipate strong EBITDA recovery driven by disciplined expense management and ongoing growth initiatives.
User avatar
Narrative Update • Oct 23

Analysts Weigh Cognex Growth Outlook Amid Valuation Changes and Activist Investor Developments

Analysts have increased their fair value estimate for Cognex from $48.00 to $48.25. This change is attributed to improving demand trends and expectations of stronger future EBITDA margins.
User avatar
Narrative Update • Oct 09

Cloud And AI Vision Solutions Will Expand Market Reach

The analyst fair value estimate for Cognex has been raised modestly from $47.21 to $48.00 per share. Analysts anticipate improved revenue growth and margin recovery, supported by disciplined cost management and ongoing investment in core strengths.
User avatar
Narrative Update • Sep 25

Cloud And AI Vision Solutions Will Expand Market Reach

Analysts have raised their price target for Cognex to $47.21, citing improving end-market demand, stronger than expected operating leverage, and sector-wide optimism on earnings growth. Analyst Commentary Improving demand across most of Cognex's end markets is expected to drive a return to more normalized upcycle operating leverage into 2026.
Analysis Article • Sep 21

When Should You Buy Cognex Corporation (NASDAQ:CGNX)?

While Cognex Corporation ( NASDAQ:CGNX ) might not have the largest market cap around , it led the NASDAQGS gainers...
User avatar
Narrative Update • Sep 10

Cloud And AI Vision Solutions Will Expand Market Reach

Analysts have trimmed their price target for Cognex to $46.17 as near-term neutrality and only modest improvements outweigh longer-term optimism for margin expansion and demand recovery in 2026. Analyst Commentary Bullish analysts expect improving demand across most end markets to drive a return to normalized upcycle operating leverage by 2026.

CEO Compensation Analysis

How has Matt Moschner's remuneration changed compared to Cognex's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 05 2026n/an/a

US$175m

Apr 05 2026n/an/a

US$143m

Dec 31 2025US$8mUS$529k

US$114m

Compensation vs Market: Matt's total compensation ($USD8.10M) is below average for companies of similar size in the US market ($USD14.74M).

Compensation vs Earnings: Insufficient data to compare Matt's compensation with company performance.


CEO

Matt Moschner (39 yo)

1.6yrs
Tenure
US$8,099,369
Compensation

Mr. Matthew Moschner, also known as Matt, is Chief Executive Officer & Director of Cognex Corporation from June 27, 2025 and serves as its President of Cognex Corporation from February 20, 2025 and served...


Leadership Team

NamePositionTenureCompensationOwnership
Matthew Moschner
President1.6yrsUS$8.10m0.0065%
$ 670.0k
Dennis Fehr
Senior VP of Finance & CFO2.3yrsUS$3.48m0.0095%
$ 983.8k
Carl Gerst
Executive Vice President of Global Sales & Products1.2yrsUS$3.66m0%
$ 0
Sheila DiPalma
Executive VP of Employee Services & Chief Culture Officer8.9yrsUS$2.19m0.0089%
$ 923.7k
Robert Shillman
Founder45.7yrsUS$216.05kno data
Mike Bowdoin
Vice President of Operations1.2yrsno data0.0066%
$ 685.6k
Laura MacDonald
VP of Finance18.8yrsUS$1.25m0.0031%
$ 325.2k
Greer Aviv
Head of Investor Relations1.3yrsno datano data
Mark Fennell
VP, Chief Legal Officer & Corporate Secretary1.2yrsno datano data
Robin Pratt
Corporate Communications Contractorno datano datano data
Didier Lacroix
Senior Vice President of Worldwide Sales & Marketingno datano datano data
Richard Morin
Secretaryno dataUS$538.28kno data
1.6yrs
Average Tenure
58yo
Average Age

Experienced Management: CGNX's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Matthew Moschner
President1.3yrsUS$8.10m0.0065%
$ 670.0k
Robert Shillman
Founder5.3yrsUS$216.05kno data
Anthony Sun
Chairman & Lead Independent Director44.7yrsUS$403.03k0.23%
$ 23.9m
Marjorie Sennett
Independent Director4.8yrsUS$345.03k0.015%
$ 1.6m
Sachin Lawande
Independent Director5.7yrsUS$340.03k0.017%
$ 1.8m
Angelos Papadimitriou
Independent Director3.6yrsUS$335.03k0.0096%
$ 998.3k
John T. Lee
Independent Director4.3yrsUS$355.03k0.015%
$ 1.5m
Sami Atiya
Independent Directorless than a yearno datano data
Christopher Donato
Independent Directorless than a yearno datano data
4.3yrs
Average Tenure
61yo
Average Age

Experienced Board: CGNX's board of directors are considered experienced (4.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 01:33
End of Day Share Price 2026/09/18 00:00
Earnings2026/07/05
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cognex Corporation is covered by 36 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert MasonBaird
Quinn FredricksonBaird
Guy HardwickBarclays

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide